FR1502631A - Method of culturing a disease virus - Google Patents

Method of culturing a disease virus

Info

Publication number
FR1502631A
FR1502631A FR41780A FR41780A FR1502631A FR 1502631 A FR1502631 A FR 1502631A FR 41780 A FR41780 A FR 41780A FR 41780 A FR41780 A FR 41780A FR 1502631 A FR1502631 A FR 1502631A
Authority
FR
France
Prior art keywords
culturing
disease virus
virus
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR41780A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Application granted granted Critical
Publication of FR1502631A publication Critical patent/FR1502631A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18451—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR41780A 1965-08-28 1965-12-10 Method of culturing a disease virus Expired FR1502631A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB83486A DE1247548B (en) 1965-08-28 1965-08-28 Process for producing a measles vaccine

Publications (1)

Publication Number Publication Date
FR1502631A true FR1502631A (en) 1967-11-24

Family

ID=6981993

Family Applications (2)

Application Number Title Priority Date Filing Date
FR41780A Expired FR1502631A (en) 1965-08-28 1965-12-10 Method of culturing a disease virus
FR52754A Expired FR5666M (en) 1965-08-28 1966-03-09

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR52754A Expired FR5666M (en) 1965-08-28 1966-03-09

Country Status (9)

Country Link
AT (1) AT281280B (en)
BE (1) BE686101A (en)
BR (1) BR6682416D0 (en)
CH (1) CH484277A (en)
DE (1) DE1247548B (en)
DK (2) DK119938B (en)
FR (2) FR1502631A (en)
GB (1) GB1161414A (en)
NL (1) NL6611851A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211843A (en) * 1977-11-30 1980-07-08 L'institut Armand-Frappier Strain of measles virus and process of producing the same
CN104498446B (en) * 2014-12-15 2017-03-15 北京科兴生物制品有限公司 A kind of method of inactivation of viruses in production of vaccine

Also Published As

Publication number Publication date
GB1161414A (en) 1969-08-13
DK121811B (en) 1971-12-06
DK119938B (en) 1971-03-15
DE1247548B (en) 1967-08-17
BR6682416D0 (en) 1973-12-04
BE686101A (en) 1967-02-28
FR5666M (en) 1968-01-02
CH484277A (en) 1970-01-15
AT281280B (en) 1970-05-11
NL6611851A (en) 1967-03-01

Similar Documents

Publication Publication Date Title
FR1383778A (en) Process for obtaining tiny capsules and capsules obtained by this process
CH528592A (en) Method of cultivating a fungal strain
FR1503235A (en) Method of preparing a new substance by culturing fungi
FR1502631A (en) Method of culturing a disease virus
FR1484638A (en) Method of culturing and inactivating a new virus
FR1466167A (en) Acrylamide isolation method
FR1513253A (en) Process for the production of inosine by fermentation
FR1496079A (en) Improved esterification process
FR1475742A (en) Method for preparing antigens
CH448046A (en) Hydrodimerization process of acrylic compounds
FR1468628A (en) New virus culture process
BR6800211D0 (en) A PROCESS FOR THE CULTURE OF A MICRO-ORGANISM
FR1459781A (en) Method for cultivating a strain of brucella abortus
FR1411111A (en) Process for the production of d-ribose-5-phosphate and d-ribose by fermentation
CH450809A (en) Process for preparing antiparasitic emulsion
CH477553A (en) Process for the preparation of a live rubella virus
FR1493259A (en) Method for cultivating a new yeast
FR1466843A (en) Mushroom cultivation process
FR1425110A (en) Emulsion production process
CH463482A (en) Process for obtaining acrylamide
FR1429734A (en) Method of culturing trypanosomes
CH449288A (en) Method of making a bound album
FR1473910A (en) Process for the preparation of a novel 3-methoxyoestradiol ester
FR1484640A (en) Arylalkylation process of phenols
CH415680A (en) Improved process for obtaining alpha-thienyl-1-phenyl-1-carbinols